Figure 7. The 786-O cell viability following (A) solasodine and (B) sappanol treatments. (C) Clonogenicity in Petri dishes with various doses of solasodine and sappanol. (D) Scratch assay in control, solasodine, and sappanol groups. (E) The number of clones formed in the 786-O cell lines. (F) Wound width in control, solasodine, and sappanol groups.